文献速递生殖医学产科

肥胖子宫环境中的晚期糖基化终产物损害植入前胚胎发育

Advanced glycation end products present in the obese uterine environment compromise preimplantation embryo development.
PubMed 文献 · Reprod Biomed Online · 2020-08-01

研究将小鼠胚胎暴露于与瘦者(1-2 µmol/l)或肥胖者(4-8 µmol/l)子宫液浓度相当的晚期糖基化终产物(AGE),发现8 µmol/l AGE降低孵化率、总细胞数、滋养外胚层细胞数和胚胎铺展。RAGE拮抗可改善第5天滋养外胚层细胞数。结论提示肥胖子宫高AGE环境可能损害胚胎发育与植入潜能。

要点

  • 8 µmol/l AGE降低小鼠第5天孵化率、总细胞数、TE细胞数及胚胎铺展。
  • RAGE拮抗可改善第5天TE细胞数,提示AGE部分经RAGE起作用。
  • 自然周期 prolonged 暴露或ART中高质量胚胎置入高AGE环境均可能受损。

核心结论

  • 与肥胖子宫环境等摩尔的AGE损害小鼠植入前胚胎发育与功能。
  • 短期RAGE拮抗对胚胎结局影响有限,提示孕前降低AGE可能有益。

研究设计与样本

  • 小鼠胚胎体外培养,AGE浓度与瘦者(1-2 µmol/l)或肥胖者(4-8 µmol/l)子宫液相当。
  • 第4、5天行差异核染色评估内细胞团与滋养外胚层细胞分配,第5天TUNEL检测凋亡。
  • 第4天胚胎置于BSA/纤连蛋白包被板,93小时后评估胚胎铺展作为植入潜能标志。
  • 药物干预包括12.5 nmol/l RAGE拮抗剂、0.1 nmol/l二甲双胍或联合抗氧化剂。

主要发现

  • 8 µmol/l AGE降低第5天孵化率(P < 0.01)。
  • 8 µmol/l AGE降低第4、5天总细胞数(P < 0.01)。
  • 8 µmol/l AGE降低第5天TE细胞数(P < 0.01)。
  • 8 µmol/l AGE降低胚胎铺展(P < 0.01)。
  • RAGE拮抗改善第5天TE细胞数。

关键数值与推荐

  • AGE浓度参考瘦者子宫液1-2 µmol/l与肥胖者4-8 µmol/l。
  • RAGE拮抗剂浓度12.5 nmol/l;二甲双胍0.1 nmol/l;联合抗氧化剂为10 µmol/l乙酰左旋肉碱、10 µmol/l N-乙酰半胱氨酸和5 µmol/l α-硫辛酸。

临床怎么用

  • 对超重/肥胖女性,孕前通过药物或饮食干预降低AGE或可改善生殖结局。
  • ART周期中应关注肥胖子宫高AGE环境对高质量胚胎植入成功的不利影响。

局限性

  • 研究为小鼠胚胎体外实验,结果外推至人类临床需谨慎。
  • 短期RAGE拮抗对胚胎结局影响有限,长期或联合干预效果未明。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Proinflammatory advanced glycation end products (AGE), highly elevated within the uterine cavity of obese women, compromise endometrial function. Do AGE also impact preimplantation embryo development and function? DESIGN: Mouse embryos were cultured in AGE equimolar to uterine fluid concentrations in lean (1-2 µmol/l) or obese (4-8 µmol/l) women. Differential nuclear staining identified cell allocation to inner cell mass (ICM) and trophectoderm (TE) (day 4 and 5 of culture). Cell apoptosis was examined by terminal deoxynucleotidyl transferase-mediated dUDP nick-end labelling assay (day 5). Day 4 embryos were placed on bovine serum albumin/fibronectin-coated plates and embryo outgrowth assessed 93 h later as a marker of implantation potential. AGE effects on cell lineage allocation were reassessed following pharmacological interventions: either 12.5 nmol/l AGE receptor (RAGE) antagonist; 0.1 nmol/l metformin; or combination of 10 µmol/l acetyl-l-carnitine, 10 µmol/l N-acetyl-l-cysteine, and 5 µmol/l alpha-lipoic acid. RESULTS: 8 µmol/l AGE reduced: hatching rates (day 5, P < 0.01); total cell number (days 4, 5, P < 0.01); TE cell number (day 5, P < 0.01), and embryo outgrowth (P < 0.01). RAGE antagonism improved day 5 TE cell number. CONCLUSIONS: AGE equimolar with the obese uterine environment detrimentally impact preimplantation embryo development. In natural cycles, prolonged exposure to AGE may developmentally compromise embryos, whereas following assisted reproductive technology cycles, placement of a high-quality embryo into an adverse 'high AGE' environment may impede implantation success. The modest impact of short-term RAGE antagonism on improving embryo outcomes indicates preconception AGE reduction via pharmacological or dietary intervention may improve reproductive outcomes for overweight/obese women.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Hutchison JC, Truong TT, Salamonsen LA, et al. Advanced glycation end products present in the obese uterine environment compromise preimplantation embryo development. Reprod Biomed Online. 2020. PMID: 32972872. doi:10.1016/j.rbmo.2020.07.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。